drugset / Trial / NCT03458156

Umbilical Cord Mesenchymal Stem Cell Transplantation for Lupus Nephritis

NCT03458156 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

To investigate the safety and efficacy of umbilical cord mesenchymal stem cell transplantation in patients with systemic lupus erythematosus (SLE) and lupus nephritis (LN).

Timeline

Start
2017-01
Primary completion
2019-09
Completion
2020-01

Drugs

EvaluationDrugModalityDoseRoute
Subject umbilical cord mesenchymal stem cell transplantation Cell therapy — —

Indications